cefminox has been researched along with dibekacin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Yokota, N | 1 |
| Arai, S; Ishii, T; Kamiya, H; Kawamura, R; Sakurai, M | 1 |
| Anandan, S; Balaji, V; Falagas, ME; Rajenderan, S; Sahni, RD; Tansarli, GS | 1 |
3 other study(ies) available for cefminox and dibekacin
| Article | Year |
|---|---|
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. II. The combined effect of arbekacin with imipenem or cefminox].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephamycins; Dibekacin; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Imipenem; Methicillin Resistance; Staphylococcus aureus | 1992 |
The in vivo and in vitro postantibiotic effect of aminoglycosides using a clinically isolated micro-organism.
Topics: Abscess; Adolescent; Ampicillin; Anti-Bacterial Agents; Cephamycins; Cloxacillin; Dibekacin; Drug Administration Schedule; Drug Therapy, Combination; Gentamicins; Humans; Male; Serratia Infections; Serratia marcescens | 1993 |
Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study.
Topics: Acinetobacter; Anti-Bacterial Agents; Cephamycins; Dibekacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Klebsiella; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Thienamycins | 2014 |